News & Trends - MedTech & Diagnostics
Out-of-pocket expenses double for Australians with private health insurance
Private health insurance (PHI) plays a crucial role in the Australian health system, with over 45% of the population currently holding PHI coverage. Despite this widespread uptake, a new study has revealed that Australians with PHI spend double the share of their disposable income on out-of-pocket medical expenses compared to those without coverage.
This raises questions about whether PHI is a good financial deal for the government as it incentivises PHI uptake to contribute to the funding and sustainability of the nation’s health system.
Independent studies commissioned by the Department of Health indicate that the Federal Government is approximately $1,400 better off for each person holding private health insurance, after considering the cost of the rebate, the foregone Medicare Levy Surcharge, and the reduction in burden on the public health system.
However, out-of-pocket expenses (OOPE) creates a policy concern if it requires a high share of income, particularly among low-income individuals who face trade-offs between healthcare and other essential goods and services.
Many PHI plans for hospital care use list prices that are lower than the hospital fee, covering only part of the costs. Consequently, OOPE is typically required for private hospital care, even when PHI and Medicare cover most of the expenses.
This suggests that PHI offers only limited protection against OOPE for individuals who require hospitalisation or use more healthcare services due to chronic conditions, while potentially offering other benefits such as choice of physician and reduced waiting times.
For lower-income individuals, “Out-of-pocket expenditure presents a significant burden, and Private health insurance does not appear to mitigate this burden. We therefore argue that, from an equity perspective, out-of-pocket expenditure is a policy concern in Australia, and our results suggest that Private health insurance does not appear to help solve it,” wrote the authors.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics
AI-assisted colonoscopy boosts polyp and adenoma detection
MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]
MoreNews & Trends - Pharmaceuticals
‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO
Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]
MoreNews & Trends - Pharmaceuticals
Government’s silence on Senate report leaves cancer patients in limbo
Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]
More